Cloned receptor paves way for new breast and prostate cancer treatment

Researchers have cloned a T-cell receptor that binds to an antigen associated with prostate cancer and breast cancer. T cells that have been genetically equipped with this T-cell receptor have the ability to specifically kill prostate and breast cancer cells.

Read the whole article on Science Daily

More from Science Daily